{"id":"https://openalex.org/W4286295304","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.6552","title":"Medicare expenditures for discarded oncology therapies.","display_name":"Medicare expenditures for discarded oncology therapies.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286295304","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.6552"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.6552","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.6552","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.6552","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042786134","display_name":"Caleb Scheckel","orcid":"https://orcid.org/0000-0002-7248-2219","observed_orcids":["https://orcid.org/0000-0002-7248-2219"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caleb Scheckel","raw_affiliation_strings":["Mayo Clinic, Division of Hematology, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Division of Hematology, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078137308","display_name":"Aakash P. Desai","orcid":"https://orcid.org/0000-0002-2943-3817","observed_orcids":["https://orcid.org/0000-0002-2943-3817"]},"institutions":[{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aakash Desai","raw_affiliation_strings":["University of Connecticut Health Center, Farmington, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut Health Center, Farmington, CT;","institution_ids":["https://openalex.org/I75929689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045829196","display_name":"Chelsee J. Jensen","orcid":"https://orcid.org/0000-0003-1954-4414","observed_orcids":["https://orcid.org/0000-0003-1954-4414"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chelsee Jensen","raw_affiliation_strings":["Mayo Clinic, ROCHESTER;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, ROCHESTER;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005887623","display_name":"Jacob J. Orme","orcid":"https://orcid.org/0000-0002-0319-0239","observed_orcids":["https://orcid.org/0000-0002-0319-0239"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Orme","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017156539","display_name":"Joshua C. Pritchett","orcid":"https://orcid.org/0000-0001-6139-5526","observed_orcids":["https://orcid.org/0000-0001-6139-5526"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Pritchett","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002142386","display_name":"Amit Mahipal","orcid":"https://orcid.org/0000-0002-1111-8333","observed_orcids":["https://orcid.org/0000-0002-1111-8333"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Mahipal","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058557833","display_name":"Nandita Khera","orcid":"https://orcid.org/0000-0002-0577-3155","observed_orcids":["https://orcid.org/0000-0002-0577-3155"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nandita Khera","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ;","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029802364","display_name":"Ronald S. Go","orcid":"https://orcid.org/0000-0002-8284-3495","observed_orcids":["https://orcid.org/0000-0002-8284-3495"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald S. Go","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"6552","last_page":"6552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.030899999663233757,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13555","display_name":"Healthcare cost, quality, practices","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-waste","display_name":"pharmaceutical waste","score":0.8690000176429749},{"id":"https://openalex.org/keywords/medicare-part-b","display_name":"Medicare Part B","score":0.7940000295639038},{"id":"https://openalex.org/keywords/infrastructure-investment-and-jobs-act","display_name":"Infrastructure Investment and Jobs Act","score":0.9819999933242798},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8370000123977661},{"id":"https://openalex.org/keywords/weight-based-dosing","display_name":"weight-based dosing","score":0.925000011920929},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":0.8999999761581421},{"id":"https://openalex.org/keywords/romiplostim","display_name":"romiplostim","score":0.8569999933242798},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.33000001311302185},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.6980000138282776},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8439031839370728},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.5709379315376282},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.4726088345050812},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4521690309047699},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4426339268684387},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21611979603767395},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.14616471529006958},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.10699838399887085},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.6552","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.6552","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.6552","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506},{"display_name":"Responsible consumption and production","id":"https://metadata.un.org/sdg/12","score":0.7811999917030334}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389220285","https://openalex.org/W7170041014","https://openalex.org/W4311931043","https://openalex.org/W4416775108","https://openalex.org/W4393005073","https://openalex.org/W2962426639","https://openalex.org/W3126955977","https://openalex.org/W2789916977","https://openalex.org/W3194237865","https://openalex.org/W7139039693"],"abstract_inverted_index":{"6552":[0],"Background:":[1],"Significant":[2],"amounts":[3],"of":[4,43,55,101,106,112,115,144,163,187,200,211,231,248,255,275,296,314,343,360,395,399],"expensive":[5],"oncology":[6,61,306,325],"drugs":[7,38,374],"are":[8],"discarded":[9,60,88,119,142,229,271,391],"resulting":[10,308],"in":[11,19,57,309,346,414],"waste":[12,107,167,260,355],"and":[13,24,84,92,108,152,195,223,240,253,291,318,379],"financial":[14],"consequences":[15],"for":[16,35,59,87,90,118,129,141,279,384],"patients.":[17],"Beginning":[18],"2023,":[20],"the":[21,44,68,109,116,157,181,205,208,245,280,319],"Infrastructure":[22],"Investment":[23],"Jobs":[25],"Act":[26],"(IIJA)":[27],"will":[28],"require":[29],"drug":[30,45,249,259,381,386],"manufacturers":[31],"to":[32,176,267,329,389,421],"refund":[33],"Medicare":[34,69,122,347],"any":[36],"single-use":[37,241,380],"where":[39],"greater":[40],"than":[41],"10%":[42,354],"is":[46],"wasted.":[47],"We":[48,66],"explored":[49],"potential":[50],"IIJA-associated":[51],"savings":[52,313,342,409],"through":[53],"assessment":[54],"patterns":[56],"spending":[58,83,322,348],"agents":[62,206,236,307,361],"between":[63],"2017-2020.":[64,77],"Methods:":[65],"utilized":[67],"Part":[70,123],"B":[71,124],"Discarded":[72],"Drug":[73],"Units":[74],"database":[75],"from":[76],"Using":[78],"J":[79],"codes,":[80],"we":[81,371],"extracted":[82,128],"reimbursement":[85,140],"data":[86,126],"medications":[89],"antineoplastic":[91],"classical":[93],"hematology":[94],"therapies.":[95,120],"The":[96,273,334],"primary":[97],"outcome":[98],"was":[99,127],"identification":[100],"therapies":[102,135,160,184,326],"with":[103,138,197,207,226,270,376,416,418],"high":[104],"percentage":[105,210],"economic":[110],"impact":[111],"retroactive":[113],"application":[114,295],"IIJA":[117,297,335],"Results:":[121],"utilization":[125],"a":[130,198,227,302,339,353,357],"median":[131,139,303,310,320,340],"77":[132],"(64-152)":[133],"oncologic":[134],"per":[136,251],"year":[137],"treatments":[143],"$590":[145],"M":[146,316,331,345],"($566-616).":[147],"From":[148],"2017-2020,":[149],"bortezomib,":[150,191],"romiplostim,":[151,194],"nab-paclitaxel":[153],"were":[154,190,214],"consistently":[155],"among":[156],"top":[158,182,282],"5":[159,183,283],"by":[161,168,185,365],"value":[162,169,186,199,230],"wasted":[164,188,212,324],"product.":[165],"Pembrolizumab":[166],"declined":[170],"significantly":[171],"after":[172],"2017":[173],"following":[174],"transition":[175],"fixed":[177],"dosing.":[178],"In":[179,203,368],"2020,":[180,204],"product":[189,213,256],"nab-paclitaxel,":[192],"trastuzumab,":[193],"cabazitaxel":[196,217,285],"$278":[201],"M.":[202,233],"highest":[209],"bortezomib":[215],"(27%),":[216],"(28%),":[218],"decitabine":[219,287],"(23%),":[220,222],"topotecan":[221,289],"azacitidine":[224,292],"(22%)":[225],"collective":[228],"$160":[232],"Notably,":[234],"these":[235,422],"have":[237,300,337],"weight-based":[238,377],"dosing":[239,378],"vials.":[242],"Based":[243],"upon":[244],"average":[246],"number":[247,274,359],"claims":[250],"recipient":[252],"volume":[254],"discarded,":[257],"eliminating":[258],"would":[261,299,327,336,362],"allow":[262],"an":[263],"additional":[264],"6564":[265],"patients":[266,278],"receive":[268],"treatment":[269],"bortezomib.":[272],"additionally":[276],"treated":[277],"other":[281],"agents:":[284],"(1216),":[286],"(1509),":[288],"(291),":[290],"(2682).":[293],"Retroactive":[294],"policy":[298],"impacted":[301],"20":[304],"(12-26)":[305],"annual":[311,321,341],"cost":[312],"$153":[315,344],"(142-157)":[317],"on":[323],"decline":[328],"$440":[330],"(410-466).":[332],"Conclusions:":[333],"yielded":[338],"if":[349],"applied":[350],"retroactively.":[351],"Given":[352],"cutoff,":[356],"limited":[358],"be":[363],"targeted":[364],"this":[366],"legislation.":[367],"our":[369],"study,":[370],"observe":[372],"that":[373],"associated":[375],"vials":[382],"account":[383],"most":[385],"waste.":[387],"Strategies":[388],"minimize":[390],"units":[392],"(through":[393],"storage":[394],"unused":[396],"product,":[397],"approval":[398],"multi-dose":[400],"vial":[401],"formulations,":[402],"or":[403],"fixed-dose":[404],"therapies)":[405],"could":[406],"yield":[407],"substantial":[408],"while":[410],"enabling":[411],"health":[412],"equity":[413],"collaboration":[415],"communities":[417],"difficult":[419],"access":[420],"drugs.":[423]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-07-21T00:00:00"}